GT Biopharma appoints Alan Urban as CFO after terminating Manu Ohri

GT Biopharma, Inc.

Manu Ohri's employment as CFO terminated effective June 3, 2024.
Alan L. Urban appointed CFO; previously CFO at SRAX, Creek Road Miners, Research Solutions.
Urban receives $375,000 base salary, up to 40% bonus, and equity award eligibility after 3 months.
Employment agreement for one-year initial term with automatic renewal and severance terms.
Urban reports to Executive Chairman & Interim CEO Michael Breen.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Alan L. Urban

Chief Financial Officer

GTBP · GT Biopharma, Inc.

Effective: 2024-06-03
Filed: June 7, 2024, 7:59 PM ET

In connection with Mr. Ohri’s termination, on June 3, 2024, the Company has appointed Alan L. Urban as the Company’s Chief Financial Officer.

Departed

Manu Ohri

Chief Financial Officer

GTBP · GT Biopharma, Inc.

Effective: 2024-06-03
Successor: Alan L. Urban
Filed: June 7, 2024, 7:59 PM ET

On June 3, 2024, Manu Ohri’s employment as Chief Financial Officer at GT Biopharma, Inc. (the “Company”) was terminated.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Alan L. Urban was appointed as Chief Financial Officer at GT Biopharma, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

In connection with Mr. Ohri’s termination, on June 3, 2024, the Company has appointed Alan L. Urban as the Company’s Chief Financial Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Manu Ohri was terminated as Chief Financial Officer at GT Biopharma, Inc..

Action: terminated
Role: Chief Financial Officer

Exact text from the filing

On June 3, 2024, Manu Ohri’s employment as Chief Financial Officer at GT Biopharma, Inc. (the “Company”) was terminated.

View on SEC.gov

GT Biopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-023195

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.